You have 5 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mantle cell

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cytomegalovirus Infections, Haematological Malignancy, Organ or Tissue Transplant; Complications Trial in Parkville (Blood

Enrolling by invitation
  • Cytomegalovirus Infections
  • +3 more
  • Blood sampling
  • Parkville, Victoria, Australia
    Royal Melbourne Hospital
Apr 28, 2022

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
Has Results
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +35 more
  • PI3K inhibitor BKM120
  • cetuximab
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Sep 14, 2021

Multiple Myeloma Trial in Worldwide (Daratumumab, Bortezomib, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Whittier, California
  • +113 more
Jan 17, 2023

Taste Bud-Derived Stem Cells in Humans

Recruiting
  • Diabetes
    • Baltimore, Maryland
      National Institute of Aging, Clinical Research Unit
    Nov 19, 2022

    Induced Pluripotent Stem Cells for Development of Novel Drug

    Recruiting
    • Inborn Errors of Metabolism
    • Skin biopsy
    • Withdraw of blood
    • Lahore, Pakistan
      Children Hospital and Institute of Child Health
    May 14, 2021

    Stage IV Renal Cell Cancer AJCC V7 Trial in Calgary, Toronto (Pembrolizumab, Stereotactic Body Radiation Therapy)

    Completed
    • Stage IV Renal Cell Cancer AJCC V7
    • Calgary, Alberta, Canada
    • +2 more
    Aug 26, 2021

    Type2 Diabetes Trial in Clichy (new quantitative imaging techniques with contast products, blood sample, second generation

    Recruiting
    • Type2 Diabetes
    • new quantitative imaging techniques with contast products
    • +2 more
    • Clichy, France
      Hôpital Beaujon
    Mar 21, 2022

    Langerhans Cell Histiocytosis Trial in Beijing (Cytarabine)

    Recruiting
    • Langerhans Cell Histiocytosis
    • Beijing, China
      Peking Union Medical College Hospital
    Jun 7, 2021

    Breast Tumors Trial in Guangzhou (IFNa-2a)

    Completed
    • Breast Neoplasms
    • Guangzhou, Guangdong, China
      Shicheng Su
    Feb 8, 2022

    Multiple Myeloma Trial in Beijing, Jiang Su Province (Belantamab mafodotin)

    Completed
    • Multiple Myeloma
    • Belantamab mafodotin
    • Beijing, China
    • +2 more
    Feb 8, 2022

    CTCL Trial in New York (StrataCTX® gel)

    Recruiting
    • CTCL
    • StrataCTX® gel
    • New York, New York
      Columbia University Medical Center, Department of Dermatology
    Aug 3, 2021

    B-Cell Reconstitution After Hematopoietic Stem Cell

    Not yet recruiting
    • Hematologic Malignancy
      • (no location specified)
      Dec 18, 2020

      Bladder Cancer Trial in India (Mycobacterium w, BCG (Bacillus Calmette-Guerin))

      Completed
      • Bladder Cancer
      • Mycobacterium w
      • BCG (Bacillus Calmette-Guerin)
      • Rajkot, Gujarat, India
      • +14 more
      Aug 14, 2021

      GVHD Trial in New York (Bortezomib, Cyclophosphamide)

      Active, not recruiting
      • GVHD
      • New York, New York
        New York University School of Medicine
      Apr 15, 2022

      Patients Treated for Giant Cells ARTEitis (Horton's Disease)

      Recruiting
      • Giant Cell Arteritis
      • Horton Disease
      • no intervention
      • Nîmes, France
        CHUNimes
      Jul 27, 2021

      NSCLC Trial in United States (MK-3475, Carboplatin, Paclitaxel)

      Active, not recruiting
      • Non-Small Cell Lung Cancer
      • La Jolla, California
      • +14 more
      Oct 1, 2021

      Brain Metastases From NSCLC (NSCLC) Trial in Worldwide (NovoTTF-200M device, Best Standard of Care)

      Recruiting
      • Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
      • NovoTTF-200M device
      • Best Standard of Care
      • Birmingham, Alabama
      • +109 more
      Jun 21, 2022

      Stage IV Pancreatic Cancer Trial in United States (cixutumumab, erlotinib HCl, gemcitabine HCl)

      Completed
      Has Results
      • Stage IV Pancreatic Cancer
      • cixutumumab
      • +2 more
      • Jonesboro, Arkansas
      • +145 more
      Jan 13, 2022

      A Open Label, Post Marketing Surveillance Study Following

      Completed
      • Transfusion Related Acute Lung Injury
      • Standard of Care
      • Los Angeles, California
      • +14 more
      Feb 16, 2022

      Thalassemia Major Trial in Ferrara (Blood component A, Blood component B)

      Completed
      • Thalassemia Major
      • Blood component A
      • Blood component B
      • Ferrara, Italy
        Day Hospital Thalassaemia and Haemoglobinopathies (DHTE)
      Nov 11, 2021

      Cytokine Release Syndrome, CAR-T Trial in Hannover, Zürich (Cytosorb)

      Recruiting
      • Cytokine Release Syndrome
      • CAR-T
      • Cytosorb
      • Hannover, Germany
      • +1 more
      Mar 26, 2021

      Lymphoma, B-Cell, Relapse/Recurrence, Refractory Lymphoma Trial in Shenzhen (dual target CAR-T cell therapy)

      Unknown status
      • Lymphoma, B-Cell
      • +3 more
      • dual target CAR-T cell therapy
      • Shenzhen, Guangdong, China
        Shenzhen University General hospital
      Jan 23, 2021

      Sickle Cell Trait and the Risk of Venous Thromboembolism

      Terminated
      Has Results
      • Thrombosis
        • Bronx, New York
          Montefiore Medical Center (Einstein)
        Dec 11, 2020

        Myeloid Hematological Malignancies Trial in Houston (Busulfan, Cyclophosphamide, Fludarabine)

        Completed
        Has Results
        • Myeloid Hematological Malignancies
        • Houston, Texas
          Texas Children's Hospital
        May 13, 2022

        Healthy Trial in Toronto (Active, Placebo)

        Completed
        • Healthy
        • Active
        • Placebo
        • Toronto, Ontario, Canada
          Goldring Centre for High Performance Sport
        Apr 17, 2021